Peptide Fix

Peptide Directory. Suppliers in the UK, US and AU, peptide information, and the research behind them. Informational only. Not medical advice. We sell nothing.

[Peptide Fix @PeptideFix]

Can you keep your strength while losing weight on tirzepatide? 🏋️

In a 40-week RCT of 120 adults aged 50–70, 3 weekly weights sessions didn't change weight loss (~22 kg) but cut lean tissue loss by 1.1 kg, and strength rose instead of falling.

https://t.co/DeWtOIfPgg

[Peptide Fix @PeptideFix]

Could one gene-therapy dose make the body produce its own GLP-1 drug? 💉

In obese mice, a single AAV dose encoding exendin-4 cut body weight by up to 22.6% over 21 days. Versions using native GLP-1 had no effect.

Mouse preprint, not yet peer reviewed.
https://t.co/BTLERnxfpb

[Peptide Fix @PeptideFix]

Why do some people barely lose weight on semaglutide? ��

In 13,725 adults (Nature Metabolism), rare GLP1R gene variant carriers lost 2.4% vs 8.8% on semaglutide, but 13.3% vs 15.2% on tirzepatide.

Real-world data, only 17 and 19 carriers.
https://t.co/4tsps375An

[Peptide Fix @PeptideFix]

@Dr_Lxngevity Good point. Test-retest reliability should be the first thing checked before acting on any aging clock, and ideally clocks get validated against real outcomes like disease and mortality, not just chronological age.

[Peptide Fix @PeptideFix]

@UniverseNow00 The bowhead work is genuinely interesting: the protein CIRBP boosted DNA repair in cells and extended lifespan in fruit flies. But nothing has tested it in people, so '200-year humans' is a big leap from cell and fly studies.

[Peptide Fix @PeptideFix]

@pepspotter Nice summary. The key caveat is the tiny carrier groups (17 on semaglutide, 19 on tirzepatide), so it needs replicating, but it's a neat example of genetics possibly explaining why some people respond to one drug and not another.

[Peptide Fix @PeptideFix]

@oasishealthapp Good that you flag the evidence level. For acrylamide, the animal cancer data come from doses far above a normal diet, and large human cohort studies have been largely inconclusive so far. Exposure over time matters more than any single reading.

[Peptide Fix @PeptideFix]

@pepfessions Ipamorelin acts on the ghrelin receptor (ghrelin is the 'hunger hormone'), so more appetite isn't surprising, and GH-raising compounds are linked to some fluid retention. Human data on it is limited; overview here: https://t.co/WySKBCUvYs

[Peptide Fix @PeptideFix]

@pepfessions 162/108 with dizziness and nausea is worth getting checked by a doctor or urgent care today rather than waiting it out. Worth keeping the vial and batch details too, since unregulated products can contain more than the label says.

[Peptide Fix @PeptideFix]

@TheDrugMoney Agreed testing is the gap. Stability is only one piece: identity, purity, sterility and endotoxin results from an independent lab are what make a COA meaningful. What we check before listing anyone: https://t.co/p7xVCjd2Qp

[Peptide Fix @PeptideFix]

@Investinc_Intel Useful reminder. For anyone following along: this is enforcement discretion for pharmacy compounding, not FDA approval, and conditions apply. Plain-English status for each of the six peptides, by country: https://t.co/ZLmV2uLV6f

[Peptide Fix @PeptideFix]

@marekhealth Agreed, it's the most misread part. It also only covers pharmacy compounding, so 'research use only' vials sold online aren't covered by it. We explain that difference here: https://t.co/VYv2xnpQUU

[Peptide Fix @PeptideFix]

@TOUCHDOWNSAINTS Worth knowing none of these combinations has been tested together in a published trial, and BPC-157 and TB-500 have very little human data even on their own. Side-by-side evidence for those two: https://t.co/EJxoUC1XZ8

[Peptide Fix @PeptideFix]

@JohnGoldman For anyone curious about the numbers: in T-REx (Nature Medicine, 120 adults aged 50 to 70 on tirzepatide), lifting 3x a week didn't change total weight loss, but strength rose over 10% with training and fell over 10% without it.

[Peptide Fix @PeptideFix]

@bschermd The detail that stands out: weight loss was almost identical (22.3 vs 22.6 kg), yet the lifting group lost 25% less lean tissue and gained over 10% strength, while strength fell over 10% without training. Strength may be the more useful endpoint.

[Peptide Fix @PeptideFix]

@Sarahq7a One difference that often gets skipped: tirzepatide is FDA-approved after large phase 3 trials, while retatrutide is still investigational, with phase 3 results only starting to publish. Evidence summary: https://t.co/Tfdyf7t7gH

[Peptide Fix @PeptideFix]

@Medscape Useful context: in ATTAIN-OSA (JAMA, 712 adults), breathing interruptions fell by about 18 vs 5 an hour on placebo at 52 weeks, similar with or without CPAP. Worth noting orforglipron is a small-molecule pill, not a peptide like semaglutide or tirzepatide.

[Peptide Fix @PeptideFix]

Could a peptide 'vaccine' help stubborn wounds heal? 🩹

Duke researchers used Coil29 peptide nanofibers to train the immune system against IL-1β. In normal and diabetic mice, chronic wounds healed faster than with anti-IL-1β antibodies.

Mouse study.
https://t.co/sD7I4L1j3v

[Peptide Fix @PeptideFix]

Could semaglutide affect motivation, not just appetite? 🧠

In a 72-person trial in adults with depression, oral semaglutide raised willingness to work for rewards vs placebo, and weight change didn't explain it.

Small, exploratory analysis.
https://t.co/KtpTKrSTaK

[Peptide Fix @PeptideFix]

Does a new weight-loss peptide raise heart risk? ❤️

In SYNCHRONIZE-CVOT (Lancet, 5,530 high-risk adults), survodutide didn't increase major heart events vs placebo (3.7% vs 4.1%). Weight fell up to 13.7% at 72 weeks.

Safety trial, not proof of benefit.
https://t.co/jT5c1U4JP4

[Peptide Fix @PeptideFix]

@peptidesgpt Good to lead with absolute scores. WOMAC pain fell about 4.5 vs 2.4 points from a baseline near 6, alongside weight loss of up to 28.7%. A clear benefit; the next question is whether the pain relief holds once weight stabilises. https://t.co/Tfdyf7t7gH